How many institutions held RXRX - RECURSION PHARMACEUTICALS, INC. - Class A Common Stock in Q4 2022?

144 institutional investors reported RXRX - RECURSION PHARMACEUTICALS, INC. - Class A Common Stock for Q4 2022. Use the holders table for investor-level position and value details.

RECURSION PHARMACEUTICALS, INC. - Class A Common Stock (RXRX)

Q: What does CUSIP 75629V104 represent in this 13F holders report?

CUSIP 75629V104 is the security identifier for RXRX - RECURSION PHARMACEUTICALS, INC. - Class A Common Stock used to aggregate holder disclosures.

CUSIP: 75629V104

Q4 2022 13F Holders as of 31 Dec 2022

Type / Class: Equity / Class A Common Stock
Shares outstanding: 514,715,255
Total 13F shares: 123,786,379
Share change: +18,005,508
Total reported value: $954,397,559
Put/Call ratio: 45%
Price per share: $7.71
Number of holders: 144
Value change: +$134,707,594
Number of buys: 82
Number of sells: 42

Quarterly Holders Quick Answers

What is CUSIP 75629V104?
CUSIP 75629V104 identifies RXRX - RECURSION PHARMACEUTICALS, INC. - Class A Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q1 2023
Previous quarter: Q3 2022

Recent filing periods for CUSIP 75629V104:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of RXRX - RECURSION PHARMACEUTICALS, INC. - Class A Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
BAILLIE GIFFORD & CO	13F	Company	— mixed-class rows	225,671,536 mixed-class rows	$866,487,000	—	30 Sep 2022	13F
ARK Investment Management LLC	13F	Company	— mixed-class rows	130,178,667 mixed-class rows	$431,423,000	—	30 Sep 2022	13F
VANGUARD GROUP INC	13F	Company	— mixed-class rows	94,256,013 mixed-class rows	$357,104,000	—	30 Sep 2022	13F
VIKING GLOBAL INVESTORS LP	13F	Company	27%	101,834,126	$317,722,000	—	30 Sep 2022	13F
Anchorage Capital Group, L.L.C.	13F	Company	18%	69,158,354	$215,774,000	—	30 Sep 2022	13F
BlackRock Finance, Inc.	13F	Company	— mixed-class rows	40,859,846 mixed-class rows	$200,933,000	—	30 Sep 2022	13F
MORGAN STANLEY	13F	Company	— mixed-class rows	54,519,917 mixed-class rows	$172,177,000	—	30 Sep 2022	13F
Lux Ventures IV, L.P.	3/4/5	Former 10% Owner	— class O/S missing	13,021,519	$137,710,376	—	07 Dec 2021	3/4/5
Amova Asset Management Americas, Inc.	13F	Company	— mixed-class rows	31,472,688 mixed-class rows	$103,681,000	—	30 Sep 2022	13F
Sumitomo Mitsui Trust Group, Inc.	13F	Company	— mixed-class rows	31,472,688 mixed-class rows	$101,885,000	—	30 Sep 2022	13F
GENERAL ATLANTIC, L.P.	13F	Individual	8.4%	32,319,896	$100,838,000	—	30 Sep 2022	13F
MIC Capital Management UK LLP	13F	Company	1.6%	8,451,758	$89,927,000	—	30 Sep 2022	13F
STATE STREET CORP	13F	Company	— mixed-class rows	17,746,445 mixed-class rows	$89,628,000	—	30 Sep 2022	13F
Data Collective IV GP, LLC	13F	Company	1.2%	5,941,120	$63,214,000	—	30 Sep 2022	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	— mixed-class rows	12,402,153 mixed-class rows	$56,231,000	—	30 Sep 2022	13F
FMR LLC	13F	Company	— mixed-class rows	5,852,019 mixed-class rows	$50,228,000	—	30 Sep 2022	13F
Laurion Capital Management LP	13F	Company	0.89%	4,587,274	$48,809,000	—	30 Sep 2022	13F
NORGES BANK	13F	Company	— mixed-class rows	4,563,620 mixed-class rows	$47,110,768	—	30 Sep 2022	13F
Obvious Management Services, L.L.C.	13F	Company	0.77%	3,985,087	$42,401,000	—	30 Sep 2022	13F
DCVC Opportunity Fund II GP, LLC	13F	Company	0.77%	3,951,141	$42,040,000	—	30 Sep 2022	13F
ALLIANCEBERNSTEIN L.P.	13F	Company	— mixed-class rows	3,436,288 mixed-class rows	$35,066,000	—	30 Sep 2022	13F
PLATINUM INVESTMENT MANAGEMENT LTD	13F	Company	0.44%	2,251,971	$23,961,000	—	30 Sep 2022	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	— mixed-class rows	4,905,229 mixed-class rows	$22,107,000	—	30 Sep 2022	13F
NORTHERN TRUST CORP	13F	Company	— mixed-class rows	4,227,682 mixed-class rows	$21,717,000	—	30 Sep 2022	13F
MV Management XI, L.L.C.	13F	Company	0.38%	1,971,908	$20,981,000	—	30 Sep 2022	13F
CREDIT SUISSE AG/	13F	Company	— mixed-class rows	2,327,905 mixed-class rows	$19,033,000	—	30 Sep 2022	13F
Nuveen Asset Management, LLC	13F	Company	— mixed-class rows	3,682,549 mixed-class rows	$17,861,000	—	30 Sep 2022	13F
HARVARD MANAGEMENT CO INC	13F	Company	0.29%	1,509,254	$16,058,000	—	30 Sep 2022	13F
Mitsubishi UFJ Trust & Banking Corp	13F	Company	— mixed-class rows	4,154,490 mixed-class rows	$15,725,000	—	30 Sep 2022	13F
Bank of New York Mellon Corp	13F	Company	— mixed-class rows	3,745,642 mixed-class rows	$15,476,000	—	30 Sep 2022	13F
Duquesne Family Office LLC	13F	Company	0.27%	1,385,950	$14,747,000	—	30 Sep 2022	13F
MIC Capital Partners (Public) Parallel Cayman, LP	3/4/5	10%+ Owner	— class O/S missing	1,388,889	$14,688,335	—	01 Nov 2021	3/4/5
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	— mixed-class rows	4,252,116 mixed-class rows	$13,541,000	—	30 Sep 2022	13F
ArchPoint Investors	13F	Company	0.22%	1,116,126	$11,876,000	—	30 Sep 2022	13F
Ensign Peak Advisors, Inc	13F	Company	— mixed-class rows	3,755,981 mixed-class rows	$11,836,000	—	30 Sep 2022	13F
Comprehensive Financial Management LLC	13F	Company	0.22%	1,109,395	$11,804,000	—	30 Sep 2022	13F
Erste Asset Management GmbH	13F	Company	— mixed-class rows	3,683,500 mixed-class rows	$11,747,790	—	30 Sep 2022	13F
BANK OF AMERICA CORP /DE/	13F	Company	— mixed-class rows	3,007,203 mixed-class rows	$10,879,000	—	30 Sep 2022	13F
MASSACHUSETTS FINANCIAL SERVICES CO /MA/	13F	Company	0.18%	950,594	$10,114,000	—	30 Sep 2022	13F
Two Sigma Ventures, LP	13F	Company	0.18%	903,400	$9,612,000	—	30 Sep 2022	13F
SCHRODER INVESTMENT MANAGEMENT GROUP	13F	Company	— mixed-class rows	2,756,326 mixed-class rows	$9,418,000	—	30 Sep 2022	13F
No Street GP LP	13F	Company	0.78%	3,000,000	$9,360,000	—	30 Sep 2022	13F
ALLEN OPERATIONS LLC	13F	Company	— mixed-class rows	2,466,653 mixed-class rows	$9,332,000	—	30 Sep 2022	13F
TITLEIST CAPITAL, LLC	13F	Company	— mixed-class rows	2,295,481 mixed-class rows	$7,430,000	—	30 Sep 2022	13F
PLUSTICK MANAGEMENT LLC	13F	Company	0.62%	2,357,470	$7,355,000	—	30 Sep 2022	13F
GOLDMAN SACHS GROUP INC	13F	Company	— mixed-class rows	1,446,151 mixed-class rows	$7,204,000	—	30 Sep 2022	13F
EQUITEC PROPRIETARY MARKETS, LLC	13F	Company	0.6%	2,286,265	$7,133,000	—	30 Sep 2022	13F
CITADEL ADVISORS LLC	13F	Company	— mixed-class rows	639,624 mixed-class rows	$5,769,000	—	30 Sep 2022	13F
Swiss National Bank	13F	Company	— mixed-class rows	1,542,700 mixed-class rows	$5,690,000	—	30 Sep 2022	13F
Neuberger Berman Group LLC	13F	Company	0.46%	1,757,421	$5,483,000	—	30 Sep 2022	13F

Institutional Holders of RECURSION PHARMACEUTICALS, INC. - Class A Common Stock (RXRX) as of Q4 2022

As of 31 Dec 2022, RECURSION PHARMACEUTICALS, INC. - Class A Common Stock (RXRX) was held by 144 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 123,786,379 shares. The largest 10 holders included BAILLIE GIFFORD & CO, BlackRock Inc., VANGUARD GROUP INC, MIC Capital Management UK LLP, STATE STREET CORP, Kinnevik AB (publ), Data Collective IV GP, LLC, Laurion Capital Management LP, FMR LLC, and NORGES BANK. This page lists 144 institutional shareholders reporting positions in this security for the Q4 2022 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q4 2022 vs Q3 2022 Across Filers

Q3 2022 holders

141

Q4 2022 holders

144

Holder diff

Investor	Q3 2022 Shares	Q4 2022 Shares	Share Diff	Share Chg %	Q3 2022 Value $	Q4 2022 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.